Next Article in Journal
Honey Bee Antiviral Immune Barriers as Affected by Multiple Stress Factors: A Novel Paradigm to Interpret Colony Health Decline and Collapse
Next Article in Special Issue
In Vitro Characteristics of Phages to Guide ‘Real Life’ Phage Therapy Suitability
Previous Article in Journal
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
Previous Article in Special Issue
The Magistral Phage
Open AccessConference Report

1st German Phage Symposium—Conference Report

1
Hohenheim Research Center for Health Sciences, University of Hohenheim, 70599 Stuttgart, Germany
2
Institute of Microbiology, University of Hohenheim, 70599 Stuttgart, Germany
3
Institute of Food Science and Biotechnology, University of Hohenheim, 70599 Stuttgart, Germany
4
Leibniz-Institute DSMZ—German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany
5
Institute of Animal Sciences, University of Hohenheim, 70599 Stuttgart, Germany
*
Author to whom correspondence should be addressed.
Viruses 2018, 10(4), 158; https://doi.org/10.3390/v10040158
Received: 13 March 2018 / Revised: 23 March 2018 / Accepted: 25 March 2018 / Published: 29 March 2018
(This article belongs to the Special Issue Hurdles for Phage Therapy (PT) to Become a Reality)
In Germany, phage research and application can be traced back to the beginning of the 20th century. However, with the triumphal march of antibiotics around the world, the significance of bacteriophages faded in most countries, and respective research mainly focused on fundamental questions and niche applications. After a century, we pay tribute to the overuse of antibiotics that led to multidrug resistance and calls for new strategies to combat pathogenic microbes. Against this background, bacteriophages came into the spotlight of researchers and practitioners again resulting in a fast growing “phage community”. In October 2017, part of this community met at the 1st German Phage Symposium to share their knowledge and experiences. The participants discussed open questions and challenges related to phage therapy and the application of phages in general. This report summarizes the presentations given, highlights the main points of the round table discussion and concludes with an outlook for the different aspects of phage application. View Full-Text
Keywords: bacteriophage; phage; horizontal gene transfer; co-evolution; phage therapy; industrial phage application; antimicrobial resistance (AMR); Germany bacteriophage; phage; horizontal gene transfer; co-evolution; phage therapy; industrial phage application; antimicrobial resistance (AMR); Germany
MDPI and ACS Style

Huber, I.; Potapova, K.; Kuhn, A.; Schmidt, H.; Hinrichs, J.; Rohde, C.; Beyer, W. 1st German Phage Symposium—Conference Report. Viruses 2018, 10, 158.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop